user avatar
Foundation Medicine
@FoundationATCG
Foundation Medicine is a precision medicine company transforming lives in cancer and other diseases. Community Guidelines: bit.ly/3iSL4jW
Boston, MA
foundationmedicine.com
Joined January 2013
707
Following
9,763
Followers
Posts
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Jan 20, 2022
    MRD detection has the promise to help guide cancer care. At @ASCO #GI22, we present data on its feasibility using a prototype of our tissue-informed personalized monitoring assay in mCRC patients who have undergone curative intent surgical resection: bit.ly/3tDpRDs
    00:00
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Oct 10, 2023
    #Announcement đź“Ł: Our tissue-informed circulating tumor DNA monitoring test is now available to all physicians in the US seeking personalized monitoring of their patients' response to treatment. More on this #Launch news: bit.ly/3rQcy3R
    00:00
    678K
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Aug 22, 2016
    What's the benefit of CGP w/ TMB? The ability to #predictbetter bit.ly/2bPhz46
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Oct 6, 2022
    Open now: We are accepting applications for a joint grant to address disparities in oncology care. Learn more about how to apply by October 25, 2022: bit.ly/3SvoRua
    00:00
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Feb 23, 2022
    Real world data can play an important role in informing precision cancer care. Alan Braly, our Senior Director of Data & Insights Delivery, shares how we’re working with this data to help improve drug development research and clinical treatment decisions. bit.ly/34VrF0K
    00:00
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Oct 8, 2016
    TMB can help predict responses to cancer immunotherapy for a range of tumor types. #ESMO16 bit.ly/2bPhz46
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Aug 23, 2016
    TMB: a new #immunotherapy response #clinicalmarker, now in FoundationOne bit.ly/2bPhz46 amp.twimg.com/v/4e2918c3-044…
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Aug 22, 2016
    Bladder, lung, uterine, melanoma & other cancers. What do they have in common? High TMB. bit.ly/2bcefff
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Aug 22, 2016
    Important news for our FoundationOne & FoundationOne Heme customers. #immunotherapy bit.ly/2bx8sDG
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Sep 27, 2022
    We are committed to helping shape the future of clinical care and research through cross-industry partnership. Open now – a Call for Grants Notification, seeking collaborative initiatives to address disparities in oncology care: bit.ly/3SvoRua
    00:00
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Oct 14, 2016
    A single assay can now help guide decisions across a wide range of therapies: bit.ly/2bdVHxZ
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Dec 8, 2017
    FoundationOne®Heme detected NTRK fusions in a set of diverse hematologic malignancies which could help guide use of more precise treatments: bit.ly/2AWRegV #ASH17
  • user avatar
    Foundation Medicine
    @FoundationATCG
    May 30, 2020
    Comprehensive genomic profiling can help inform cancer treatment decisions. Dr. Alexa Schrock shares how #LiquidBiopsy and tissue biopsy were used in METex14 NSCLC in our #ASCO20 study with @DanaFarber. Learn more: ow.ly/GJrh50zUbn2
    00:00
  • user avatar
    Foundation Medicine
    @FoundationATCG
    Dec 6, 2017
    We'll be at #ASH17 presenting new data supporting the ability of FoundationOne®Heme to advance precision medicine in #bloodcancers. bit.ly/2jXxwqG